Singapore markets closed

IDEAYA Biosciences, Inc. (30J.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
37.60-0.80 (-2.08%)
At close: 08:01AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-131,844
-112,961
-58,655
-49,762
-34,495
Depreciation & amortisation
4,130
4,008
3,515
3,032
1,381
Stock-based compensation
21,142
18,489
11,629
8,237
3,609
Change in working capital
-11,264
-13,207
-42,969
-19,120
84,406
Accounts receivable
453
193
892
774
-1,877
Accounts payable
2,194
2,635
1,864
1,166
225
Other working capital
-134,845
-117,592
-90,618
-58,423
54,970
Net cash provided by operating activities
-131,195
-115,224
-87,175
-55,779
55,463
Cash flows from investing activities
Investments in property, plant and equipment
-3,650
-2,368
-3,443
-2,644
-493
Purchases of investments
-999,465
-595,980
-255,808
-314,996
-242,314
Sales/maturities of investments
467,167
439,892
225,847
247,974
96,564
Net cash used for investing activities
-535,948
-158,456
-33,404
-69,666
-146,243
Cash flows from financing activities
Common stock issued
650,853
309,763
94,962
143,253
127,234
Net cash used provided by (used for) financing activities
708,902
362,717
97,165
145,454
128,750
Net change in cash
41,759
89,037
-23,414
20,009
37,970
Cash at beginning of period
67,343
68,738
92,152
72,143
34,173
Cash at end of period
109,102
157,775
68,738
92,152
72,143
Free cash flow
Operating cash flow
-131,195
-115,224
-87,175
-55,779
55,463
Capital expenditure
-3,650
-2,368
-3,443
-2,644
-493
Free cash flow
-134,845
-117,592
-90,618
-58,423
54,970